Cargando…
A pipeline for identification and validation of tumor-specific antigens in a mouse model of metastatic breast cancer
Cancer immunotherapy continues to make headway as a treatment for advanced stage tumors, revealing an urgent need to understand the fundamentals of anti-tumor immune responses. Noteworthy is a scarcity of data pertaining to the breadth and specificity of tumor-specific T cell responses in metastatic...
Autores principales: | DeVette, Christa I., Gundlapalli, Harika, Lai, Shu-Chin Alicia, McMurtrey, Curtis P., Hoover, Ashley R., Gurung, Hem R., Chen, Wei R., Welm, Alana L., Hildebrand, William H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959440/ https://www.ncbi.nlm.nih.gov/pubmed/32002300 http://dx.doi.org/10.1080/2162402X.2019.1685300 |
Ejemplares similares
-
Inhibition of RON kinase potentiates anti-CTLA-4 immunotherapy to shrink breast tumors and prevent metastatic outgrowth
por: Ekiz, Huseyin Atakan, et al.
Publicado: (2018) -
Antigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survival
por: Liu, Kaili, et al.
Publicado: (2022) -
Single‐cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing
por: Hoover, Ashley R., et al.
Publicado: (2022) -
Blocking Short-Form Ron Eliminates Breast Cancer Metastases through Accumulation of Stem-Like CD4(+) T Cells That Subvert Immunosuppression
por: Lai, Shu-Chin Alicia, et al.
Publicado: (2021) -
The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation Reprogramming
por: Cunha, Stéphanie, et al.
Publicado: (2014)